Skip to main content

Table 3 Short- and long-term odds ratios considering adiponectin.

From: Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study

 

Adiponectin quartiles

Short-term follow-up

 

I - III

IV

Crude

Adjusted*

 

n = 627

n = 209

OR

95% CI

OR

95% CI

Death

10 (1.6)

2 (1.0)

0.6

0.4-5.7

0.4

0.1-2.0

MI/PCI

15 (2.4)

5 (2.4)

1.0

0.4-2.8

1.0

0.3-2.7

Stroke

20 (3.2)

11 (5.3)

1.7

0.8-3.6

1.5

0.7-3.3

Renal failure

33 (5.3)

22 (10.5)

2.1

1.2-3.7

1.4

0.7-2.7

Re-exploration

54 (8.6)

22 (10.5)

1.2

0.7-2.1

0.9

0.6-1.9

Infections

29 (4.6)

11 (5.3)

1.1

0.6-2.3

1.0

0.5-2.1

CVD composite

43 (6.9)

17 (8.1)

1.2

0.7-2.2

1.0

0.6-1.9

 

Adiponectin quartiles

Long-term follow-up

 

I - III

IV

Crude

Adjusted ‡

 

n = 617

n = 207

OR

95% CI

OR

95% CI

Death

13 (2.1)

17 (8.2)

4.2

2.0-8.7

2.9

1.3-6.4

MI/PCI

18 (2.9)

4 (1.9)

0.7

0.2-2.0

0.7

0.2-2.1

Stroke

8 (1.3)

5 (2.4)

1.9

0.6-5.8

1.4

0.4-4.5

Infections

18 (2.9)

10 (4.8)

1.7

0.8-3.7

1.1

0.5-2.6

CVD composite

36 (5.8)

23 (11.1)

2.0

1.2-3.5

1.7

0.9-3.1

  1. * Adjusted for the logistic EuroSCORE
  2. † Adjusted for the logistic EuroSCORE and estimated glomerular filtration rate
  3. ‡ Adjusted for the logistic EuroSCORE, Charlson Comorbidity Index and type of surgery
  4. Short-term is defined as 30-day follow-up
  5. Long-term is defined as follow-up from day 31 until 365
  6. CI - Confidence interval; CVD - Cardiovascular disease; MI - Myocardial infarction; OR - Odds ratio; PCI - Percutaneous coronary intervention